Literature DB >> 19687353

Cardiovascular side effects of antiobesity drugs: a yellow flag in the race to safe pharmacotherapy for obesity.

Allyn L Mark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19687353      PMCID： PMC3101020          DOI： 10.1161/CIRCULATIONAHA.109.888529

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin.

Authors:  Kamal Rahmouni; William G Haynes; Donald A Morgan; Allyn L Mark
Journal:  J Neurosci       Date:  2003-07-09       Impact factor: 6.167

2.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

3.  Chronic cardiovascular and renal actions of leptin: role of adrenergic activity.

Authors:  Megan Carlyle; Oscar B Jones; Jay J Kuo; John E Hall
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

4.  PTP1B regulates leptin signal transduction in vivo.

Authors:  Janice M Zabolotny; Kendra K Bence-Hanulec; Alain Stricker-Krongrad; Fawaz Haj; Yongping Wang; Yasuhiko Minokoshi; Young-Bum Kim; Joel K Elmquist; Louis A Tartaglia; Barbara B Kahn; Benjamin G Neel
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

5.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.

Authors:  Alan Cheng; Noriko Uetani; Paul D Simoncic; Vikas P Chaubey; Ailsa Lee-Loy; C Jane McGlade; Brian P Kennedy; Michel L Tremblay
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

6.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.

Authors:  I Sadaf Farooqi; Julia M Keogh; Giles S H Yeo; Emma J Lank; Tim Cheetham; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

7.  Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity.

Authors:  Hiroyuki Mori; Reiko Hanada; Toshikatsu Hanada; Daisuke Aki; Ryuichi Mashima; Hitomi Nishinakamura; Takehiro Torisu; Kenneth R Chien; Hideo Yasukawa; Akihiko Yoshimura
Journal:  Nat Med       Date:  2004-06-20       Impact factor: 53.440

8.  Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function.

Authors:  Eric J Belin de Chantemèle; Kenjiro Muta; James Mintz; Michel L Tremblay; Mario B Marrero; David J Fulton; David W Stepp
Journal:  Circulation       Date:  2009-08-17       Impact factor: 29.690

Review 9.  Obesity wars: molecular progress confronts an expanding epidemic.

Authors:  Jeffrey S Flier
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

10.  Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3.

Authors:  Jane K Howard; Belinda J Cave; Laura J Oksanen; Iphigenia Tzameli; Christian Bjørbaek; Jeffrey S Flier
Journal:  Nat Med       Date:  2004-06-27       Impact factor: 53.440
View more
  1 in total

Review 1.  The Arcuate Nucleus of the Hypothalamus and Metabolic Regulation: An Emerging Role for Renin-Angiotensin Pathways.

Authors:  Darren Mehay; Yuval Silberman; Amy C Arnold
Journal:  Int J Mol Sci       Date:  2021-06-30       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.